These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19252172)

  • 1. Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?
    Passweg JR; Tichelli A
    Haematologica; 2009 Mar; 94(3):310-2. PubMed ID: 19252172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
    He G; Zhang X; Wu D; Sun A; Wang X
    Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
    Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
    Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.
    Frickhofen N; Rosenfeld SJ
    Semin Hematol; 2000 Jan; 37(1):56-68. PubMed ID: 10676911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Gupta V; Bhatia B
    Indian J Pediatr; 2009 Sep; 76(9):970-1; author reply 971-2. PubMed ID: 19381516
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
    Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
    West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression with ALG and CsA is first line treatment in children with SAA lacking an HLA identical sibling.
    Békássy AN; Locasciulli A; Marsh JC; Socié G; Fuehrer M; Passweg J
    Pediatr Blood Cancer; 2005 Sep; 45(3):359-60; author reply 361-2. PubMed ID: 15940724
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive therapy for aplastic anemia--review].
    Xu CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.
    Takabayashi M; Sakai R; Sakamoto H; Iemoto Y; Kanamori H; Inayama Y; Ishigatsubo Y
    Anticancer Drugs; 2003 Mar; 14(3):251-3. PubMed ID: 12634621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune suppression for childhood acquired aplastic anemia and myelodysplastic syndrome: where next?
    Samarasinghe S; Marsh J; Dufour C
    Haematologica; 2014 Apr; 99(4):597-9. PubMed ID: 24688105
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
    Chandra J; Naithani R; Ravi R; Singh V; Narayan S; Sharma S; Pemde H; Dutta AK
    Indian J Pediatr; 2008 Mar; 75(3):229-33. PubMed ID: 18376089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
    Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
    Ann Intern Med; 1999 Feb; 130(3):193-201. PubMed ID: 10049197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
    Kanakura M; Mihara H; Wakabayashi M; Tajima E; Hiramatsu A; Sato A; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):1036-8. PubMed ID: 11985078
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
    Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
    Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients.
    Futagi Y; Suga Y; Shimada T; Sai Y
    Ann Hematol; 2023 Feb; 102(2):463-465. PubMed ID: 36435888
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations.
    Reddy V; Khan S; Wingard JR; Mehta P
    Blood; 1999 Sep; 94(5):1833-4. PubMed ID: 10507843
    [No Abstract]   [Full Text] [Related]  

  • 18. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.